• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tubular effects of sodium-glucose cotransporter 2 inhibitors: intended and unintended consequences.钠-葡萄糖共转运蛋白 2 抑制剂的管状作用:预期和非预期的后果。
Curr Opin Nephrol Hypertens. 2020 Sep;29(5):523-530. doi: 10.1097/MNH.0000000000000632.
2
A role for tubular Na/H exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin.管腔 Na/H 交换器 NHE3 在 SGLT2 抑制剂恩格列净的利钠作用中的作用。
Am J Physiol Renal Physiol. 2020 Oct 1;319(4):F712-F728. doi: 10.1152/ajprenal.00264.2020. Epub 2020 Sep 7.
3
SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.SGLT2 抑制和肾脏尿酸排泄:管腔葡萄糖、GLUT9 和 URAT1 的作用。
Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F173-F185. doi: 10.1152/ajprenal.00462.2018. Epub 2018 Nov 14.
4
SGLT2-independent effects of canagliflozin on NHE3 and mitochondrial complex I activity inhibit proximal tubule fluid transport and albumin uptake.卡格列净对NHE3和线粒体复合物I活性的非SGLT2依赖性作用抑制近端小管液体转运和白蛋白摄取。
Am J Physiol Renal Physiol. 2024 Jun 1;326(6):F1041-F1053. doi: 10.1152/ajprenal.00005.2024. Epub 2024 Apr 25.
5
Renal upregulation of NCC counteracts empagliflozin-mediated NHE3 inhibition in normotensive but not in hypertensive male rat.在正常血压的雄性大鼠中,肾脏上调 NCC 可抵消恩格列净介导的 NHE3 抑制,但在高血压大鼠中则不然。
Am J Physiol Cell Physiol. 2024 Jun 1;326(6):C1573-C1589. doi: 10.1152/ajpcell.00351.2023. Epub 2024 Apr 1.
6
Cardioprotection conferred by sodium-glucose cotransporter 2 inhibitors: a renal proximal tubule perspective.钠-葡萄糖共转运蛋白 2 抑制剂的心脏保护作用:从肾脏近端小管的角度来看。
Am J Physiol Cell Physiol. 2020 Feb 1;318(2):C328-C336. doi: 10.1152/ajpcell.00275.2019. Epub 2019 Nov 13.
7
Functional role of glucose metabolism, osmotic stress, and sodium-glucose cotransporter isoform-mediated transport on Na+/H+ exchanger isoform 3 activity in the renal proximal tubule.葡萄糖代谢、渗透应激以及钠-葡萄糖协同转运蛋白异构体介导的转运在肾近端小管钠/氢交换体异构体3活性中的功能作用。
J Am Soc Nephrol. 2014 Sep;25(9):2028-39. doi: 10.1681/ASN.2013060588. Epub 2014 Mar 20.
8
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update.糖尿病肾脏中钠-葡萄糖协同转运蛋白2抑制作用的最新进展
Curr Opin Nephrol Hypertens. 2016 Jan;25(1):50-8. doi: 10.1097/MNH.0000000000000187.
9
Renal Effects of Sodium-Glucose Co-Transporter Inhibitors.钠-葡萄糖协同转运蛋白抑制剂的肾脏作用。
Am J Cardiol. 2019 Dec 15;124 Suppl 1(Suppl 1):S28-S35. doi: 10.1016/j.amjcard.2019.10.027.
10
Model-Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin.基于模型的健康和糖尿病患者近端钠重吸收的 SGLT2 评估及坎格列净抑制作用
J Clin Pharmacol. 2018 Mar;58(3):377-385. doi: 10.1002/jcph.1030. Epub 2017 Nov 16.

引用本文的文献

1
The multifaceted modulations by dapagliflozin in preventing hyperglycemia-induced diabetic nephropathy through glucose transporters and PPARα.达格列净通过葡萄糖转运蛋白和过氧化物酶体增殖物激活受体α(PPARα)对预防高血糖诱导的糖尿病肾病的多方面调节作用。
J Diabetes Metab Disord. 2025 Jun 20;24(2):154. doi: 10.1007/s40200-025-01670-0. eCollection 2025 Dec.
2
Euglycemic Diabetic Ketoacidosis, Recurrent Genital Abscess, and Proximal Renal Tubular Acidosis With Concurrent SGLT-2 Inhibitor: More Than an Association.正常血糖性糖尿病酮症酸中毒、复发性生殖器脓肿与近端肾小管酸中毒合并SGLT-2抑制剂:不仅仅是一种关联。
Cureus. 2024 Aug 22;16(8):e67481. doi: 10.7759/cureus.67481. eCollection 2024 Aug.
3
Proximal tubule hypertrophy and hyperfunction: a novel pathophysiological feature in disease states.近端肾小管肥大和功能亢进:疾病状态下的一种新的病理生理特征。
Clin Kidney J. 2024 Jun 25;17(7):sfae195. doi: 10.1093/ckj/sfae195. eCollection 2024 Jul.
4
View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences.二甲双胍综述:降糖及多效性作用、药代动力学、副作用及性别相关差异
Pharmaceuticals (Basel). 2024 Apr 8;17(4):478. doi: 10.3390/ph17040478.
5
SGLT2-independent effects of canagliflozin on NHE3 and mitochondrial complex I activity inhibit proximal tubule fluid transport and albumin uptake.卡格列净对NHE3和线粒体复合物I活性的非SGLT2依赖性作用抑制近端小管液体转运和白蛋白摄取。
Am J Physiol Renal Physiol. 2024 Jun 1;326(6):F1041-F1053. doi: 10.1152/ajprenal.00005.2024. Epub 2024 Apr 25.
6
Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice.在糖尿病前期小鼠中,慢性恩格列净导致的肾脏细胞代谢、结构和功能的新生变化。
Am J Physiol Cell Physiol. 2024 Apr 1;326(4):C1272-C1290. doi: 10.1152/ajpcell.00446.2023. Epub 2024 Mar 4.
7
New functions and roles of the Na-H-exchanger NHE3.钠氢交换体 NHE3 的新功能和新角色。
Pflugers Arch. 2024 Apr;476(4):505-516. doi: 10.1007/s00424-024-02938-9. Epub 2024 Mar 7.
8
Comment on "Sodium glucose cotransporter 2 inhibitors and gout risk".关于《钠-葡萄糖协同转运蛋白2抑制剂与痛风风险》的评论
Clin Rheumatol. 2024 Feb;43(2):835-836. doi: 10.1007/s10067-023-06791-6. Epub 2023 Oct 12.
9
Medium- and Long-Term Effects of Dapagliflozin on Serum Uric Acid Level in Patients with Type 2 Diabetes: A Real-World Study.达格列净对2型糖尿病患者血清尿酸水平的中长期影响:一项真实世界研究
J Pers Med. 2022 Dec 22;13(1):21. doi: 10.3390/jpm13010021.
10
Renal Metabolome in Obese Mice Treated with Empagliflozin Suggests a Reduction in Cellular Respiration.恩格列净治疗肥胖小鼠的肾脏代谢组学研究提示细胞呼吸减少。
Biomolecules. 2022 Aug 25;12(9):1176. doi: 10.3390/biom12091176.

本文引用的文献

1
SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients.钠-葡萄糖协同转运蛋白2抑制剂治疗难治性低镁血症:3例病例报告
Kidney Med. 2020 Apr 18;2(3):359-364. doi: 10.1016/j.xkme.2020.01.010. eCollection 2020 May-Jun.
2
The tubular hypothesis of nephron filtration and diabetic kidney disease.管状假说在肾单位滤过和糖尿病肾病中的作用。
Nat Rev Nephrol. 2020 Jun;16(6):317-336. doi: 10.1038/s41581-020-0256-y. Epub 2020 Mar 9.
3
Osmotic diuresis by SGLT2 inhibition stimulates vasopressin-induced water reabsorption to maintain body fluid volume.通过抑制SGLT2产生的渗透性利尿刺激血管加压素诱导的水重吸收,以维持体液量。
Physiol Rep. 2020 Jan;8(2):e14360. doi: 10.14814/phy2.14360.
4
Genetic ablation of SGLT2 function in mice impairs tissue mineral density but does not affect fracture resistance of bone.在小鼠中敲除 SGLT2 的功能会损害组织矿物质密度,但不会影响骨的抗骨折能力。
Bone. 2020 Apr;133:115254. doi: 10.1016/j.bone.2020.115254. Epub 2020 Jan 25.
5
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2019 年更新版:《2018 年美国糖尿病协会(ADA)与欧洲糖尿病研究协会(EASD)关于 2 型糖尿病患者高血糖管理的共识报告》。
Diabetes Care. 2020 Feb;43(2):487-493. doi: 10.2337/dci19-0066. Epub 2019 Dec 19.
6
Renal effects of SGLT2 inhibitors: an update.SGLT2 抑制剂的肾脏作用:更新。
Curr Opin Nephrol Hypertens. 2020 Mar;29(2):190-198. doi: 10.1097/MNH.0000000000000584.
7
Renal Effects of Sodium-Glucose Co-Transporter Inhibitors.钠-葡萄糖协同转运蛋白抑制剂的肾脏作用。
Am J Cardiol. 2019 Dec 15;124 Suppl 1(Suppl 1):S28-S35. doi: 10.1016/j.amjcard.2019.10.027.
8
Regulation of serum uric acid with canagliflozin monotherapy in type 2 diabetes: A potential link between uric acid and pancreatic β-cell function
.卡格列净单药治疗对2型糖尿病患者血清尿酸的调控作用:尿酸与胰腺β细胞功能之间的潜在联系
Int J Clin Pharmacol Ther. 2019 Dec;57(12):590-595. doi: 10.5414/CP203513.
9
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会(ESC)与欧洲糖尿病研究协会(EASD)合作制定的糖尿病、糖尿病前期和心血管疾病指南。
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.
10
Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes.钠-葡萄糖协同转运蛋白2抑制剂与2型糖尿病患者的骨折风险
Diabetes Care. 2019 Sep;42(9):e150-e152. doi: 10.2337/dc19-0849. Epub 2019 Jul 11.

钠-葡萄糖共转运蛋白 2 抑制剂的管状作用:预期和非预期的后果。

Tubular effects of sodium-glucose cotransporter 2 inhibitors: intended and unintended consequences.

机构信息

Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida, USA.

出版信息

Curr Opin Nephrol Hypertens. 2020 Sep;29(5):523-530. doi: 10.1097/MNH.0000000000000632.

DOI:10.1097/MNH.0000000000000632
PMID:32701600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8772383/
Abstract

PURPOSE OF REVIEW

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are antihyperglycemic drugs that act by inhibiting renal sodium-glucose cotransport. Here we present new insights into 'off target', or indirect, effects of SGLT2 inhibitors.

RECENT FINDINGS

SGLT2 inhibition causes an acute increase in urinary glucose excretion. In addition to lowering blood glucose, there are several other effects that contribute to the overall beneficial renal and cardiovascular effects. Reabsorption of about 66% of sodium is accomplished in the proximal tubule and dependent on the sodium-hydrogen exchanger isoform 3 (NHE3). SGLT2 colocalizes with NHE3, and high glucose levels reduce NHE3 activity. The proximal tubule is also responsible for the majority of phosphate (Pi) reabsorption. SGLT2 inhibition is associated with increases in plasma Pi, fibroblast growth factor 23 and parathyroid hormone levels in nondiabetics and type 2 diabetes mellitus. Studies in humans identified a urate-lowering effect by SGLT2 inhibition which is possibly mediated by urate transporter 1 (URAT1) and/or glucose transporter member 9 in the proximal tubule. Of note, magnesium levels were also found to increase under SGLT2 inhibition, an effect that was preserved in nondiabetic patients with hypomagnesemia.

SUMMARY

Cardiorenal effects of SGLT2 inhibition might involve, in addition to direct effects on glucose homeostasis, effects on NHE3, phosphate, urate, and magnesium homeostasis.

摘要

目的综述

钠-葡萄糖共转运蛋白 2(SGLT2)抑制剂是通过抑制肾脏钠-葡萄糖共转运而起作用的抗高血糖药物。在这里,我们提出了 SGLT2 抑制剂的“非靶点”或间接作用的新见解。

最近的发现

SGLT2 抑制会导致尿糖排泄的急性增加。除了降低血糖外,还有其他几种作用有助于整体有益的肾脏和心血管作用。大约 66%的钠在近端小管中被重吸收,并且依赖于钠-氢交换体同工型 3(NHE3)。SGLT2 与 NHE3 共定位,并且高葡萄糖水平降低 NHE3 活性。近端小管还负责大部分磷酸盐(Pi)的重吸收。SGLT2 抑制与非糖尿病和 2 型糖尿病患者的血浆 Pi、成纤维细胞生长因子 23 和甲状旁腺激素水平的增加相关。在人类中的研究发现 SGLT2 抑制具有降低尿酸的作用,这可能是通过近端小管中的尿酸转运蛋白 1(URAT1)和/或葡萄糖转运体成员 9 介导的。值得注意的是,还发现镁水平在 SGLT2 抑制下增加,在非糖尿病伴低镁血症的患者中这种作用得以保留。

总结

SGLT2 抑制的心脏肾脏作用除了对葡萄糖稳态的直接作用外,还可能涉及 NHE3、磷酸盐、尿酸和镁稳态的作用。